Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Free Cash Flow (2010 - 2026)

Analysis

Cerenome (CNSY) Free Cash Flow (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn -
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn - -389.61 Mn
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 477.44 Mn
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn -95.09 Mn
10 Cerenome 20.42 Mn 11.83 Mn - -7.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.63 Mn
Mar 31, 2026 -7.06 Mn
Dec 31, 2025 -6.31 Mn
Sep 30, 2025 -2.58 Mn
Jun 30, 2025 -5.81 Mn
Mar 31, 2025 -6.18 Mn
Dec 31, 2024 -1.22 Mn
Sep 30, 2024 -3.69 Mn
Jun 30, 2024 -1.23 Mn
Mar 31, 2024 -4.55 Mn
Dec 31, 2023 634,000.00
Sep 30, 2023 -2.41 Mn
Jun 30, 2023 -2.79 Mn
Mar 31, 2023 -5.89 Mn
Dec 31, 2022 -5.25 Mn
Sep 30, 2022 -3.23 Mn
Jun 30, 2022 -2.78 Mn
Mar 31, 2022 -4.09 Mn
Dec 31, 2021 -2.63 Mn
Sep 30, 2021 -2.31 Mn